17beta-hydroxysteroid dehydrogenase 1 inhibitors (ElexoPharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name17beta-hydroxysteroid dehydrogenase 1 inhibitors (ElexoPharma)
Drug Alias Name17beta-Hydroxysteroid Dehydrogenase 1 inhibitors (ElexoPharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstradiol 17-beta-dehydrogenase 1 inhibitors
TargetsEstradiol 17-beta-dehydrogenase 1
Therapy Area/IndicationsEndometriosisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElexoPharm Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElexoPharm Gmbh
Active IndicationsN/A
Inactive IndicationsEndometriosisBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A